Objective: To evaluate the health-related quality of life in myotonic dystrophy type 1 and its relationships with clinical, genetic, neuropsychological and emotional factors. Design: Case-control study of a continuous series of patients with myotonic dystrophy type 1. Patients and methods: Twenty patients, and 20 age-, sex- and education-matched healthy controls underwent the MOS 36Item Short-Form Health Survey (SF-36), an extensive neuropsychological battery and emotional functioning tests. Results: Patients' SF-36 mean scores were lower than those of controls in all dimensions. The neuropsychological study showed a significant impairment in visuospatial and verba
BACKGROUND: Myotonic Dystrophy type 1 (DM1) is primarily a neuromuscular disease but can also have n...
The aim of the present study is to explore whether affective and cognitive social cognition impairme...
Background: Apathy in DM1 has long been acknowledged in clinical practice. However, a major drawback...
Objective: To evaluate the health-related quality of life in myotonic dystrophy type 1 and its relat...
Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterize...
BACKGROUND: Adult-onset myotonic dystrophy type 1 (DM1) is a chronic, multisystem disorder that lead...
Makiko Endo,1 Kaori Odaira,2 Ryohei Ono,3 Go Kurauchi,4 Atsushi Koseki,5 Momoko Goto,3 Yumi Sato,4 S...
Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterize...
Duchenne muscular dystrophy and myotonic dystrophy are genetic, progressive muscle diseases. These m...
Background: Central nervous system involvement occurs in most patients with myotonic dystrophy type ...
Objective: The objective of this cross-sectional, observational study was to investigate the dise...
Aims The cognitive profile of Myotonic Dystrophy type 1 (DM1) has been described in recent decade...
Objectives: The objective of this cross‐sectional, observational study was to investigate performan...
: Aim: To investigate the cortical thickness in myotonic dystrophy type 1 (DM1) and its potential as...
OBJECTIVES: Myotonic dystrophy type 1 (DM1) is a multisystem disorder. Many tests in the literature ...
BACKGROUND: Myotonic Dystrophy type 1 (DM1) is primarily a neuromuscular disease but can also have n...
The aim of the present study is to explore whether affective and cognitive social cognition impairme...
Background: Apathy in DM1 has long been acknowledged in clinical practice. However, a major drawback...
Objective: To evaluate the health-related quality of life in myotonic dystrophy type 1 and its relat...
Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterize...
BACKGROUND: Adult-onset myotonic dystrophy type 1 (DM1) is a chronic, multisystem disorder that lead...
Makiko Endo,1 Kaori Odaira,2 Ryohei Ono,3 Go Kurauchi,4 Atsushi Koseki,5 Momoko Goto,3 Yumi Sato,4 S...
Introduction: Myotonic Dystrophy Type 1 (DM1) is an autosomal dominant genetic illness, characterize...
Duchenne muscular dystrophy and myotonic dystrophy are genetic, progressive muscle diseases. These m...
Background: Central nervous system involvement occurs in most patients with myotonic dystrophy type ...
Objective: The objective of this cross-sectional, observational study was to investigate the dise...
Aims The cognitive profile of Myotonic Dystrophy type 1 (DM1) has been described in recent decade...
Objectives: The objective of this cross‐sectional, observational study was to investigate performan...
: Aim: To investigate the cortical thickness in myotonic dystrophy type 1 (DM1) and its potential as...
OBJECTIVES: Myotonic dystrophy type 1 (DM1) is a multisystem disorder. Many tests in the literature ...
BACKGROUND: Myotonic Dystrophy type 1 (DM1) is primarily a neuromuscular disease but can also have n...
The aim of the present study is to explore whether affective and cognitive social cognition impairme...
Background: Apathy in DM1 has long been acknowledged in clinical practice. However, a major drawback...